Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
SAN JUAN, Puerto Rico–(BUSINESS WIRE)–EVERTEC, Inc. (NYSE: EVTC) (“EVERTEC” or the “Company”) today announced that President and Chief Executive Officer, Mac Schuessler will be presenting at the Raymond James 41st Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 3, 2020 at 1:05 pm ET.
Investors and interested parties can access an archive of the presentation by visiting the Company’s investor relations website at http://ir.evertecinc.com/.
About Evertec
EVERTEC, Inc. (NYSE: EVTC) is a leading full-service transaction processing business in Latin America, providing a broad range of merchant acquiring, payment processing and business solutions services. The Company manages a system of electronic payment networks that process more than two billion transactions annually and offers a comprehensive suite of services for core bank processing, cash processing and technology outsourcing. In addition, EVERTEC owns and operates the ATH® network, one of the leading personal identification number (“PIN”) debit networks in Latin America. Based in Puerto Rico, the Company operates in 26 Latin American countries and serves a diversified customer base of leading financial institutions, merchants, corporations and government agencies with “mission-critical” technology solutions. For more information, visit www.evertecinc.com.
Contacts
Investor Contact
Kay Sharpton
(787) 773-5442
IR@evertecinc.com
BROOKLYN, N.Y., June 8, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Forest Young…
IIG's constructed, owned-and-operated northern corridor is attracting strong customer demand, with further expansion already under…
As of the 2025 filing season, the IRS is applying First-Time Abatement automatically - without…
WASHINGTON, DC / ACCESS Newswire / June 8, 2026 / AGS Health®, a leading provider…
Proof-of-concept SHEPHERD study will assess SUL-238's effects on mitochondrial function in patients with Parkinson's disease.…
FAIRFIELD, NJ / ACCESS Newswire / June 8, 2026 / Jerash Holdings (US), Inc. (Nasdaq:JRSH),…